TP53BP1 and metastatic carcinoma: Furthermore, we suggest that IF analysis of 53BP1 expression may be a good ancillary technique to distinguish metastatic carcinoma or ETT from TFIs in LNs, particularly in cases other than BRAFV600E-mutated PTC.